Back to 
Federated Hermes, Inc.
Federated Hermes, Inc.
STOK
Showing 0 of 16 quarters
Position history for Federated Hermes, Inc.'s holdings in Stoke Therapeutics, Inc.
No. Federated Hermes exited its STOK (Stoke Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 1,076 shares worth $4,239. Federated Hermes first reported STOK in Q2 2019 and held it in 14 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of STOK: FMR LLC, RTW Investments, LP, BlackRock, Inc.